| scholarly article | Q13442814 |
| P50 | author | Stephen Hamilton-Dutoit | Q42323196 |
| P2093 | author name string | Xiao-ge Zhou | |
| Steffen Junker | |||
| Christina B Hertel | |||
| P2860 | cites work | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 | Q22010683 |
| Translating the Histone Code | Q22065840 | ||
| Regulation of BOB.1/OBF.1 stability by SIAH | Q24291513 | ||
| Selectivity of chromatin-remodelling cofactors for ligand-activated transcription | Q24292110 | ||
| OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins | Q24313516 | ||
| The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1 | Q24550350 | ||
| Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia | Q24554417 | ||
| B-cell-specific DNA binding by an E47 homodimer | Q24651446 | ||
| Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells | Q27860599 | ||
| ATP-dependent remodeling and acetylation as regulators of chromatin fluidity | Q28145156 | ||
| Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation | Q28200064 | ||
| Cancer epigenetics comes of age | Q29617275 | ||
| BSAP can repress enhancer activity by targeting PU.1 function | Q33786904 | ||
| Stepwise specification of lymphocyte developmental lineages. | Q33964101 | ||
| The Reed-Sternberg cell in classical Hodgkin's disease | Q34199578 | ||
| Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin | Q34450725 | ||
| SWI/SNF chromatin remodeling and cancer | Q34493162 | ||
| Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. | Q36404030 | ||
| E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins | Q36686388 | ||
| NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation | Q36686647 | ||
| B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. | Q38302908 | ||
| A human early B-cell factor-like protein participates in the regulation of the human CD19 promoter. | Q38314892 | ||
| Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3' enhancer | Q38326073 | ||
| PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors | Q40445382 | ||
| Combinatorial regulation of transcription II: The immunoglobulin mu heavy chain gene. | Q40525538 | ||
| Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. | Q40807422 | ||
| Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription | Q40832778 | ||
| Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. | Q40937465 | ||
| Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division | Q40967060 | ||
| Gene targeting reveals a hierarchy of transcription factors regulating specification of lymphoid cell fates | Q41049000 | ||
| Dependence of BSAP repressor and activator functions on BSAP concentration | Q41052202 | ||
| E47 activates the Ig-heavy chain and TdT loci in non-B cells. | Q41077263 | ||
| Murine and human 3'IgH regulatory sequences | Q41600324 | ||
| Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line | Q41672433 | ||
| Temporal control of IgH gene expression in developing B cells by the 3' locus control region | Q41689020 | ||
| Extinction of an immunoglobulin kappa promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression | Q41734568 | ||
| Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments | Q42642886 | ||
| An enhancer element in the short unique region of human cytomegalovirus regulates the production of a group of abundant immediate early transcripts | Q48330090 | ||
| Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. | Q51065317 | ||
| Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc. | Q52196302 | ||
| Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. | Q52214235 | ||
| THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE | Q57198332 | ||
| Dedifferentiation of mammalian myotubes induced by msx1 | Q73406479 | ||
| Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in classic Hodgkin's disease | Q73664503 | ||
| MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes | Q74424976 | ||
| Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry | Q77430266 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4908-4920 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. | |
| P478 | volume | 21 |
| Q30855570 | Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China |
| Q35607200 | Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma |
| Q54987213 | Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma. |
| Q39986630 | Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. |
| Q36545556 | Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma |
| Q35788374 | Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma |
| Q24556523 | Accumulation of miR-155 and BIC RNA in human B cell lymphomas |
| Q41969041 | Bob-1 is expressed in classic Hodgkin lymphoma |
| Q38138482 | CD30 as a therapeutic target for lymphoma |
| Q39454046 | CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation |
| Q58704308 | Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma |
| Q38818058 | Comparative proteomic profiling of Hodgkin lymphoma cell lines. |
| Q59357963 | Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma |
| Q38596350 | Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma |
| Q38973626 | Deregulated FOX genes in Hodgkin lymphoma |
| Q44305871 | Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria |
| Q36403618 | Differential requirement for OBF-1 during antibody-secreting cell differentiation |
| Q40669895 | Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines |
| Q41537617 | ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and down-regulated in classical Hodgkin's lymphoma |
| Q45428861 | Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus. |
| Q34576340 | Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions |
| Q37039112 | Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo |
| Q56930876 | Epstein-Barr virus-associated lymphomas |
| Q36338375 | Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. |
| Q24675877 | Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas |
| Q83223363 | Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays |
| Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q57272184 | HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma |
| Q35216401 | Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions |
| Q33588862 | Hodgkin lymphoma: an update on its biology with new insights into classification |
| Q92482943 | Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis |
| Q36591359 | IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis |
| Q64069464 | Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist |
| Q40337542 | Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma |
| Q40864458 | Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think? |
| Q34750551 | Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma |
| Q28208976 | OCA-B regulation of B-cell development and function |
| Q43595419 | PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature. |
| Q35618780 | Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells |
| Q34185759 | Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? |
| Q34438875 | Rare expression of T-cell markers in classical Hodgkin's lymphoma |
| Q34557179 | Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies |
| Q37004635 | Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell |
| Q36495569 | Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins |
| Q39240522 | Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma |
| Q35639424 | SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma |
| Q35552528 | Somatic hypermutation patterns in germinal center B cell malignancies |
| Q79276796 | The B-Cell Transcription Factors BSAP, Oct-2, and BOB.1 and the Pan-B-Cell Markers CD20, CD22, and CD79a Are Useful in the Differential Diagnosis of Classic Hodgkin Lymphoma |
| Q28306121 | The ID proteins: master regulators of cancer stem cells and tumour aggressiveness |
| Q55515687 | The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes. |
| Q37349652 | The biology of Hodgkin's lymphoma |
| Q58099160 | The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G |
| Q34626576 | The molecular pathogenesis of Hodgkin lymphoma. |
| Q80387153 | The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms |
| Q33301651 | Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern |
| Q57802286 | Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma |
Search more.